Celecoxib

塞来昔布

Report date: 2026/03/30 20:02:02
NME

Base Information

Drug NameCelecoxib
Drug Alias Name塞来考昔NiflamCelecoxibumNu-CelecoxibOnsenal +[21] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2
Therapy Area/IndicationsRespiratory papillomatosisNon-radiographic axial spondyloarthritisLarge intestine neoplasm +[78] 
Global Approved IndicationsAcute PainDysmenorrheaOsteoarthritis +[7] 
Approved Indications in ChinaAcute PainOsteoarthritisArthritis, Rheumatoid +[4] 
Original Approved Country/TerritoryUnited States
Original Approved Date1998/12/31
Country/TerritoryCzechiaBelgiumCanada +[45] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesUpjohn IncINTERNATIONAL BIO SERVICES CO LTDG. D. Searle & Co +[13] 
Inactive CompaniesUtah State UniversityDana-Farber Cancer InstituteViatris +[49] 
Active IndicationsObsessive-Compulsive DisorderLow Back PainAcute Pain +[25] 
Inactive IndicationsRespiratory papillomatosisNon-radiographic axial spondyloarthritisLarge intestine neoplasm +[53] 

Other Information

ATC CodeL01XX33M01AH01
Related LinksWikipediaDrugBankKEGG